Research Shows Pacific Edge’s Cxbladder Detect Outperforms Other Non-Invasive Bladder Cancer Diagno
Dunedin, NZ and Hershey, PA (May 25, 2015): Newly published research demonstrates that Cxbladder out performs other non-invasive bladder cancer diagnostics, announced Pacific Edge, Ltd. The... read more
Pacific Edge Announces User Programme with Singapore General Hospital
Cancer diagnostics company, Pacific Edge Limited (NZX: PEB) has signed an agreement with Singapore General Hospital (SGH), the country’s first and largest hospital, to conduct a... read more
Positive Results in Kaiser Permanente User Programme
Cancer diagnostics company Pacific Edge (NZX: PEB) has advised that it has successfully completed its analysis of the data from the large scale Kaiser Permanente (Kaiser)... read more
Cxbladder Monitor Paper to be Published in Prestigious Journal of Urology
Cxbladder Monitor shows superior performance in ruling out recurrence of bladder cancer The prestigious American Journal of Urology has accepted for publication a paper confirming the superior... read more
Pacific Edge Commences Official Launch of Cxbladder Monitor in the USA
Cancer diagnostics company, Pacific Edge Limited (NZX:PEB) has commenced the official USA launch of its third bladder cancer diagnostic test, Cxbladder Monitor. Cxbladder Monitor is Pacific Edge’s... read more
Pacific Edge Launches Cxbladder Resolve - The Fourth Product in Suite of Cxbladder Tests
Another step change for urologists and their patients Cancer diagnostics company, Pacific Edge Limited (NZX: PEB) has today launched Cxbladder Resolve, the fourth product in the Cxbladder... read more
2017
Cxbladder Monitor Significantly Outperforms FDA Approved Urine Tests for Bladder Cancer
Cxbladder Monitor clinical paper accepted for publication in Journal of Urologic Oncology The prestigious international journal Urologic Oncology, has accepted for publication a scientific and clinical paper... read more
Significant Increase in Clinical Utility from Use of Cxbladder
An international study demonstrates compelling changes in urologists’ clinical decisions, with use of Cxbladder Triage and Cxbladder Detect leading to fewer total tests and less invasive... read more
GenomeWeb: Pacific Edge Bladder Cancer Recurrence Test Outperforms Others in Head-to-Head Comparison
by Elizabeth Newbern NEW YORK (GenomeWeb) – A recently published study by researchers from New Zealand-based diagnostic firm Pacific Edge and collaborators has shown that the firm's... read more